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INTRODUCTION
Multiple sclerosis (MS) is chronic inflammatory demyelina-
ting disease of the central nervous system (CNS), and the 
leading cause of disability in young adults. Considering that 
inflammation can affect any part of the CNS, this disease can 
present itself with myriad of symptoms, thus it is sometimes 
called “the disease with thousand faces”. Symptoms that pa-
tients develop are caused by inflammation leading to demye-
lination (i.e. the disruption of the myelin sheath) which results 
in slowing of impulse conduction through neuronal pathways, 
and functional deficits in systems innervated by demyelinated 
nerve fibres (e.g. locomotor and sensory system). For exam-
ple, one of the more important and frequently affected fun-
ctions, particularly in patients with longer disease duration, is 
walking. According to North American Research Committee 
on Multiple Sclerosis registry 45% of MS patients aged 
between 18-64 years use some form of mobility devices (1). 
Moreover, MS is the leading cause of wheelchair use in this 
age group (2). It is only recently that a wider range of drugs 
for treating MS became available, and they can be divided in 
two groups, i.e. the first and second line. The second line of 
treatment includes more efficient drugs, but with more seve-
re possible side-effects. This line of treatment is used in pa-
tients with more aggressive disease course or in patients who 
were unresponsive to the first line treatment.
Considering this wider range of therapies available today, one 
of the challenges is to estimate which therapy is the best 
choice for specific patient taking into account his or her cu-
rrent health state and factors which may indicate future co-
urse of disease in this patient. In addition to neurological 
examination, brain and cervical spinal cord magnetic reso-
nance imaging (MRI) is typically used in order to gain insi-
ght into patients’ current state and disease activity. Studies 
have shown that demyelinating lesions detected with the 
MRI in some parts of the CNS, such as the brainstem, carry 
higher risk for worse disease course (3-5). On the other hand, 
it is also known that MRI findings do not always correlate 
with clinical finding, meaning that patient may have some 
symptoms, but no corresponding lesions are evident on MRI. 
The latter is referred to as the clinico-radiological paradox 
(6), which is particularly emphasized in the brainstem region 
(7). Thus there is a need for additional methods and tools for 
assessing different neurological system, and evoked poten-
tials are one of these methods.
EVOKED POTENTIALS
Evoked potentials (EP) are a group of different slightly di-
fferent diagnostic procedures, but all share the same prin-
ciple; the response of specific neural pathway to appropria-
te stimulation is recorded and analysed. Using this principle, 
numerous neural pathways and systems can be inspected, 
for example somatosensory system (somatosensory evoked 
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potentials – SSEP), vestibular (vestibular evoked myogenic 
potentials – VEMP), visual (visual evoked potentials – 
VEP), auditory (brainstem auditory evoked potentials – 
BAEP), and motor system. For instance, one of the most 
commonly used types of stimuli is the electric impulse. The 
electric impulse is sensed by sensory nerve fibres which 
then emit the information from the place of stimulation (e.g. 
ankle) to cerebral sensory cortex. The sensory information 
is transduced as a transient “travelling” change of the ele-
ctric potential on the membrane of nerve cells, and these 
changes in the electric potential (so called evoked poten-
tials) can be recorded via electrodes placed along the exa-
mined neural pathway. Several parameters of the recorded 
response are analysed (i.e. the amplitude, latency and morp-
hology of the response) and compared to the referent values 
of healthy population. The name of the recorded response 
(the so called “wave”) usually contains information on the 
polarity of electric potential change (i.e. positive (P) or ne-
gative (N)), and the approximate time (measured in milli-
seconds) needed for the evoked potential to travel the 
distance from the site of stimulation to the measuring ele-
ctrode in healthy population. For example, P100 wave des-
cribes positive change of the electric potential measured at 
100 ms after the stimulation.
THE ROLE OF EVOKED POTENTIALS 
IN MULTIPLE SCLEROSIS
The role of EPs in the assessment of MS patients changed 
over time, and with the emergence of new technologies, 
especially the magnetic resonance imaging (MRI), EPs 
were unjustifiably considered less useful. In recent years 
EPs are becoming increasingly important in MS diagnosti-
cs, which is clearly reflected in the fact that visual evoked 
potentials became enlisted in the new criteria for diagnosing 
MS (8). In contrast to imaging methods, such as the MRI, 
EPs can give us insight in the actual function of the speci-
fic neural pathway. Since demyelinating inflammation of 
the central nervous system is the hallmark of MS, typical 
finding on EPs in MS are prolonged latencies of responses. 
Other common findings are decreased amplitudes or even 
absence of response depending on the degree of damage of 
myelin sheaths or neurons themselves.
VISUAL EVOKED POTENTIALS (VEP)
Considering that the first manifestation of MS in about 
20% of patients is the inflammation of the optic nerve 
(i.e. optic neuritis – ON), VEPs are one of the most com-
monly used methods among Eps (9). Typical finding on 
VEP in the acute phase of ON are prolonged latencies 
(Figure 1) and reduced amplitudes of the responses. Al-
though the amplitudes of VEP responses return to normal 
some time after the ON, the latency of the response usu-
ally remains prolonged. The sensitivity for identifying a 
patient who experienced ON some time in the past is 
77-100% (10, 11). It is for this reason that VEPs can be 
used for estimating whether the patient fulfils one of the 
criteria for diagnosing MS, i.e. the dissemination in time.
SMATOSENSORY EVOKED POTENTIALS (SSEP)
SSEPs of upper and lower extremities can give us insight 
in the function of somatosensory pathway in dorsal colu-
mns of the spinal cord and thalamo-cortical sensory system 
in the brain. The value of evoked potentials as a method 
lies primarily in their ability to detect subclinical damage 
of the nervous system, and SSEPs of lower extremities (Fi-
gure 2) are considered to be one of the most valuable met-
hods among Eps (12). Studies have shown that SSEPs of 
lower extremities can detect the damage of spinal cord so-
matosensory system in as much as 80% of MS patients 
without corresponding clinical symptoms (13).
Fig. 1: An example of prolonged latency of visual evoked potential res-
ponse. P100 wave was recorded more than 120 ms after the stimulation.
Fig. 2: An example of normal response recorded during SSEP of lower 
extremities. In this diagnostic procedure tibial nerve is stimulated via 
electric impulse at the level of ankle, and the responses are recorded at 
several spinal cord levels, as well as over sensory cortex of the brain.
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BRAINSTEM EVOKED POTENTIALS
Brainstem auditory evoked potentials (BAEP) and vestibu-
lar evoked myogenic potentials (VEMP) evaluate the fun-
ction of auditory and vestibular system (i.e. system respon-
sible for sense of balance) at the level of the brainstem. 
While BAEP is one of the least sensitive methods among 
EPs (14), VEMP has been shown to be superior compared 
to BAEP, as well as compared to neurological exam and 
brain MRI (15). SSEP of the trigeminal nerve has also pro-
ven to be valuable in detecting lesions of upper portion of 
the brainstem (i.e. the mesencephalon) in MS patients (16).
THE EVOKED POTENTIAL SCORE
Considering that by using different EP methods various par-
ts of the nervous system can be evaluated, an idea to create 
an indicator of the global state of function of MS patients’ 
nervous system was born. By marking every VEP and BAEP 
response, and motor and SSEP responses of upper and lower 
extremities according to hypothetical degree of damage, and 
summing-up all of the result, Leocani et al. developed the 
so-called evoked potential score (EP score). In this model 
normal responses were marked as 0, prolonged latencies as 
1, abnormal morphologies of waves was marked as 2, and 
an absence of response was marked as 3 (17). In this longi-
tudinal study patients were followed-up for about three years, 
and EP score correlated well with neurologist’s clinical fin-
dings, but it also showed predictive value. Subjects who had 
EP score higher than the median of this sample had 72.5% 
higher risk for clinical worsening in the control period. Also, 
another retrospective study with longer follow-up period 
confirmed the predictive value of EP score (18).
One of the shortfalls of both studies is that only BAEP 
was used to evaluate the function of the brainstem. This 
is especially important considering the before-mentioned 
correlation between brainstem lesions and higher risk for 
worse course of the disease. It is for that reason that the 
VEMP score was developed. VEMP score correlated well 
with both clinical and MRI findings of brainstem integri-
ty, and it also had independent predictive value of clinical 
state of MS patients (19, 20). The value of VEMP score 
as a predictor of disease course is still a matter of study.
CONCLUSION
Evoked potentials are very valuable neurophysiological met-
hod in diagnostics and follow-up of MS patients. The biggest 
advantage of EPs is the ability to detect subclinical damage 
of the nervous system. Also, considering that this method 
gives us information about the functional state of the inspected 
neural pathway, it is complementary to MRI when evaluating 
MS patients. Some studies have shown that by using a battery 
of EPs can be used to gain better understanding of the current 
state of individual MS patient, and can even be used to iden-
tify patients at higher risk of disease progression. This predi-
ctive value is especially important when deciding which 
therapy is the most suitable one for specific MS patient.
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